Consistent with our previous finding showing that KLF4 suppresses liver cancer growth [15], the results of this study showed that DUB3 inhibited HCC cell proliferation in vitro and tumor growth in vivo in a KLF4-dependent manner. Here, USP17L2 is linked to liver cancer.